MedPath

Schema Therapy for Dissociative Identity Disorder

Recruiting
Conditions
Dissociative Identity Disorder
Registration Number
NL-OMON25486
Lead Sponsor
niversity of Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
32
Inclusion Criteria

•Main diagnosis of Dissociative Identity Disorder, diagnosed with the SCID-D-R
•The initial Dissociative Identity Disorder diagnosis was classified max 3 years ago
•Participant has not received schema therapy before
•Participant has not completed successful trauma treatment
•Participant is motivated to undertake trauma treatment and to actively participate in achieving the treatment goals (reading literature at home, doing home assignments etc.) and to practice behavioral change
•Participant agrees to be recorded; in diagnostic interviews on video and treatment sessions on audio
•Age = 18 and < 60
•Participant is able to understand, read, write, and speak Dutch

Exclusion Criteria

•DSM-5 substance dependence, as measured with the MINI-plus, that requires detox
•Florid psychotic episodes, as determined with the MINI-plus
•Acute suicide risk, as measured with several questions on suicidal behavior, which are administered as part of the intake.
•IQ < 80. IQ testing is requested by default by the intaker when education level is lower than intermediate vocational education. In that case, the screener for intelligence and mild intellectual disability (SCIL) is administered, with further IQ tests (WAIS) if indicated
•Other comorbid Axis I and Axis II disorders are allowed. They will be classified with the MINI-plus and the SCID-5-PD

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Dissociative symptoms (DSS), Post Traumatic Stress Disorder symptoms (PCL-5), Symptoms clusters of Dissociative Identity Disorder: depersonalisation, derealisation, identity confusion and amnesia (SCID-D-R), therapy dropout percentage.
Secondary Outcome Measures
NameTimeMethod
Trait dissociation (DES), a selection of validity scales from the Multidimensional Inventory of Dissociation (MID), metamemory beliefs (DBMQ), unusual sleep experiences (ISES), personality functioning and personality traits (SIPP-SF, PID-5-Brief Form), outcomes related to schema therapy (YSQ3-SF, SMI-2), daily functioning (WHODAS 2.0), happiness, quality of therapeutic relation (WAI-SR) and experiential avoidance (AAQ-II).
© Copyright 2025. All Rights Reserved by MedPath